Two Sigma Securities’s Cytosorbents Corp CTSO Stock Holding History

Two Sigma Securities’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,737	Closed	-$14.7K	–	1572
2025 Q3	$14.7K	Buy	+15,737	New	+$15.5K	﹤0.01%	1175
2025 Q2	–	Sell	-15,287	Closed	-$15.3K	–	1598
2025 Q1	$15.3K	Buy	+15,287	New	+$16.1K	﹤0.01%	1153
2024 Q4	–	Sell	-12,155	Closed	-$18.2K	–	1972
2024 Q3	$18.2K	Buy	+12,155	New	+$13.3K	﹤0.01%	2511

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Two Sigma Securities's CTSO Position: Q4 2025 in Review

Two Sigma Securities sold out of Cytosorbents Corp (CTSO) in Q4 2025, closing a stake of 15,737 shares — an estimated $14.7K sold.

Two Sigma Securities first reported a position in CTSO in Q3 2024 and held it in 3 quarters. The position peaked at $18.2K in Q3 2024. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2025.

Two Sigma Securities reported no remaining Cytosorbents Corp position as of Q4 2025 after selling out during the quarter.
Two Sigma Securities sold 15,737 Cytosorbents Corp shares in Q4 2025, an estimated $14.7K.
Two Sigma Securities first reported a position in Cytosorbents Corp in Q3 2024 and held it in 3 quarters.
Two Sigma Securities's Cytosorbents Corp position peaked at $18.2K in Q3 2024.
51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.